FindTrial
Sign In

Hemoperfusion,Control

2 trials

Sponsors

Faculty of Medicine, Chiang Mai University

Conditions

COVID-19 patients (Severe and critical) Early hemoperfusion , Severe and critical COVID-19Dengue shock syndrome patients admitted to the Intensive Care Units Cytokine storm, Dengue, Dengue shock syndrome, Hemoperfusion

Phase 2

The efficacy of early HA-330 hemoperfusion for severe and critical COVID-19 patients in a tertiary hospital : A randomized control trial
Active, not recruitingTCTR20211102004
COVID-19 patients (Severe and critical) Early hemoperfusion , Severe and critical COVID-19
Start: 2021-11-08Target: 24Updated: 2026-08-03

Unknown Phase

The Efficacy of Hemoperfusion Therapy in Patients with Dengue Shock Syndrome
Active, not recruitingTCTR20250513003
Faculty of Medicine, Chiang Mai UniversityDengue shock syndrome patients admitted to the Intensive Care Units Cytokine storm, Dengue, Dengue shock syndrome, Hemoperfusion
Start: 2025-05-15Target: 96Updated: 2026-08-03